Home
Transdermal and Microneedle Drug Delivery
10 November - 11 November 2025
Transdermal and Microneedle Drug Delivery

Have you considered that microneedle drug delivery systems could revolutionise the future of vaccine and drug administration?

Discover the future of drug delivery at SAE’s 4th annual Transdermal and Microneedle Drug Delivery conference, where we lead the transition beyond the needle.

Collaborate with forward-thinking experts in a high-level 2-day program, discussing case studies and real-world examples in delivery R&D, vaccine application, and diversifying capabilities.

Transdermal and Microneedle Array Patches (MAPs) are revolutionizing pharmaceutical development, offering unparalleled potency, increased community access, consistent long-term delivery, and advanced diagnostic capabilities, making this technology a frontrunner in enhancing efficacy and global access to transformative products.
 

FEATURED SPEAKERS

Ajoy Chakrabarti

Ajoy Chakrabarti

Portfolio & Platform Lead, Polio, Bill & Melinda Gates Foundation (Subject to Final Confirmation)
Amir Reichman

Amir Reichman

CEO, Scinai Immunotherapeutics Ltd.
Arabe Ahmed

Arabe Ahmed

Medicinal Technical Specialist, BSI
Brian Pfister

Brian Pfister

Vice President, Gylden Pharma
John Burt

John Burt

CEO, Medherant
Mateusz Hasso-Agopsowicz

Mateusz Hasso-Agopsowicz

Technical Officer, World Health Organization
Muhammet Avcil

Muhammet Avcil

Managing Director, Imperial BioScience
Renske Hesselink

Renske Hesselink

Director MSC Innovations, Coalition for Epidemic Preparedness Innovations (CEPI)
Sanjiv Sharma

Sanjiv Sharma

Senior Lecturer in Medical Engineering, Swansea University

Ajoy Chakrabarti

Portfolio & Platform Lead, Polio, Bill & Melinda Gates Foundation (Subject to Final Confirmation)
Ajoy Chakrabarti

Amir Reichman

CEO, Scinai Immunotherapeutics Ltd.
Amir Reichman

Mr. Amir Reichman was appointed CEO of Scinai in 2021. He previously led Global Vaccines Engineering Core Technologies at GSK in Belgium and held senior roles in GSK’s global supply chain after its acquisition of Novartis Vaccines, where he served in operational leadership roles in the U.S.
Mr. Reichman’s academic work at Ben-Gurion University contributed to founding NeuroDerm, later acquired for $1.1B. He was its first employee and served as a Senior Scientist. He holds an M.Sc. in Biotechnology Engineering from Ben-Gurion University and an MBA from the Wharton School, University of Pennsylvania.
 

Arabe Ahmed

Medicinal Technical Specialist, BSI
Arabe Ahmed

Arabe Ahmed is a Medicinal Expert in drug–device combination products at BSI, where his role is to provide specialist pharmaceutical affairs, regulatory and strategic support to medical devices and pharmaceutical companies. Prior to joining BSI, Arabe worked for more than 10 years for GSK and Novartis in the UK, and Germany respectively in various pharmaceutical development roles. He holds a doctorate degree in drug delivery research from Julius Maximilian University of Würzburg, Germany, and masters degree in Pharmaceutical Technology form King's College London. In addition, Arabe is a UK registered pharmacist and member of the Royal Pharmaceutical Society of Great Britain.

Brian Pfister

Vice President, Gylden Pharma
Brian Pfister

Dr. Brian Pfister is a Vice President at Gylden USA Corp. where he leads US operations. Gylden USA is a wholly owned subsidiary of UK based Gylden Pharma Limited, a clinical-stage, privately held biotechnology company pioneering the development of 100% synthetic CD8+ T cell-priming immune set-point therapeutic candidates that harness and direct the body’s natural T cell immune response. Brian received his Ph.D. in biochemistry from Rush University and M.B.A. from the University of Notre Dame.

James Birchall

Deputy Head of School, Cardiff University
James Birchall

John Burt

CEO, Medherant
John Burt

Appointed as CEO of Medherant in 2019 to lead the company in developing novel transdermal drug delivery patches, John Burt was CEO of Abzena plc, a contract research, development and manufacturing organization for biopharmaceuticals, where he led multiple financing rounds, including an AIM IPO in 2014, and grew the business by acquisitions in the UK and US through to the group’s acquisition by private equity firm, Welsh Carson Anderson & Stowe in 2018. He was previously co-founder and CEO of Thiakis, a metabolic disease therapeutic development company that he founded with Professor Steve Bloom out of Imperial College London and subsequently sold to Wyeth in 2008. His early career included finance, business and corporate development roles with Coopers & Lybrand (PwC), Vanguard Medica, Glaxo Wellcome / GlaxoSmithKline and Imperial Innovations. John gained his doctorate in Plant Sciences from University of Oxford following his undergraduate degree in Natural Sciences (Biochemistry) from University of Cambridge.

Mateusz Hasso-Agopsowicz

Technical Officer, World Health Organization
Mateusz Hasso-Agopsowicz

Muhammet Avcil

Managing Director, Imperial BioScience
Muhammet Avcil

Dr Muhammet Avcil gained his honours degree in Chemistry and an MSc in Molecular Synthesis (Organic Syntheses) from the University of Sussex. After his MSc, He worked as a Research Assistant at the University of Sussex. He conducted his PhD research at the University of Sussex and Imperial College London. He has over 19 years of experience in biotechnology, drug discovery and development, working at universities and senior management positions in various institutions. He is a key figure in the management and strategic development of Imperial Bioscience and continues to get involved in the research and development of the company.
 

Renske Hesselink

Director MSC Innovations, Coalition for Epidemic Preparedness Innovations (CEPI)
Renske Hesselink

Sanjiv Sharma

Senior Lecturer in Medical Engineering, Swansea University
Sanjiv Sharma

Dr Sanjiv Sharma received his PhD on the development of analytical methods for determination of certain pharmaceuticals and their metabolites using miniaturised separation system in 2001. On completion of his fellowship he joined the Institute of Biomedical Engineering, Imperial College London to work with Professor Tony Cass in the area of Bionanotechnology and Biosensors. Here he developed minimally invasive microneedles, from photolithographic fabrication to high throughput fabrication, taking these microneedles from the lab to the clinic . Sanjiv was involved in a NIHR (i4i) funded research project involving clinical studies in healthy volunteers and participants with T1D with renowned Endocrinologist Clinicians; Professor Desmond Johnston and Professor Nick Oliver. He has published over 50 research articles and has patents filed in Germany, UK and the United States.
Sanjiv is currently a Senior Lecturer in Medical Engineering in the College of Engineering at Swansea University. At Swansea, he is working on therapeutic drug delivery and diagnostic (theranostic) applications of polymeric microneedles.
 


Portfolio & Platform Lead, Polio
Bill & Melinda Gates Foundation (Subject to Final Confirmation)
CEO
Scinai Immunotherapeutics Ltd.
Medicinal Technical Specialist
BSI
Vice President
Gylden Pharma
Deputy Head of School
Cardiff University
CEO
Medherant
Technical Officer
World Health Organization
Managing Director
Imperial BioScience
Director MSC Innovations
Coalition for Epidemic Preparedness Innovations (CEPI)
Senior Lecturer in Medical Engineering
Swansea University

Official Media Partner

VENUE

Hilton London Kensington

179-199 Holland Park Avenue, London, United Kingdom

At the heart of the Holland Park district, our hotel is 10 minutes from Westfield London shopping center. We're blocks from Shepherd's Bush Underground station, linking to central London, and Kensington Palace and Gardens are two miles from us. Enjoy 24-hour access to our fitness center.

 
Join us in WestEleven for hearty buffet breakfast, a great way to start the day! Our Avenue Bar and Lounge serves light bites throughout the day as well as a delicious, seasonal dining menu.”

A number of our clients have been approached by third party organisations offering to book hotel rooms. We would advise that you do not book through them as they are not representing SMi Group Trading As SAE Media Group. SMi Group Trading As SAE Media Group books all hotel rooms directly. If you are approached by a third-party organisation then please contact us before making any bookings. If you have already booked a hotel room using a third-party organisation, we would highly recommend contacting the hotel you were booked into to ensure a booking has been made for you. We would also advise you to please check the terms and conditions of the booking carefully.
HOTEL BOOKING FORM

Media Partners


Pharma Journalist

Official Media Partner
http://www.pharmajournalist.com

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry. Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry. Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.


The Medicine Maker

Official Media Partner
https://themedicinemaker.com/?utm_source=media_partner_24&utm_medium=event&utm_campaign=sae_media_logo

The Medicine Maker is a print and digital publication as well as a weekly newsletter. At The Medicine Maker, we bring people into the limelight, showcasing the industry’s success stories and examining its biggest points of contention. Engaging content covers the entire spectrum of drug development, keeping all medicine makers up to date with the most pressing topics, trends and technologies driving the pharma industry forward. Register for your FREE print or digital magazine or subscribe to our newsletter here! https://themedicinemaker.com/?utm_source=media_partner_24&utm_medium=event&utm_campaign=sae_media_logo


Drug Development and Delivery

Official Media Partner
http://drug-dev.com/

Drug Development & Delivery, including its exclusive Specialty Pharma section, is a print publication, conference organizer (Drug Development Networking Summit), and online content provider exclusively committed to advancing the applied science, technology, and related business practices of pharmaceutical and biological drug development, reporting on formulation design, bioavailability and solubility enhancement, drug delivery and platform technologies, life cycle management, compound-enabling strategies, business development, outsourcing services, and partnerships and collaborations. Through insightful scientific, business, news, and technology-related formats, Drug Development & Delivery provides pharmaceutical professionals with practical solutions to the issues, opportunities, and challenges in the ever-evolving drug development communities. We complement your business development initiatives, connecting you with and influencing the audiences that matter most to you: investors, business partners, technology and service seekers, and regulatory agencies.


pharmaphorum

Official Media Partner
http://www.pharmaphorum.com

pharmaphorum drives innovation within the pharmaceutical industry, by bringing healthcare together through a suite of media services that help produce and disseminate thought leadership, combined with an online platform for communicating messages to a global audience.Visit www.pharmaphorum.com


ONdrugDelivery

Official Media Partner
http://ondrugdelivery.com

ONdrugDelivery provides readers throughout global pharma/biopharma with the latest, most pertinent industry information and intelligence about the drug delivery-related ideas, technologies, services and products the sector is developing. Established in 2004, and trusted throughout the industry for its high quality contributions from leading drug delivery experts, ONdrugDelivery is a must for pharma / biotech industry professionals who need to know what’s going on in drug delivery. Subscribe online today to the print or free digital edition: ondrugdelivery.com/subscribe

SAVE TO


Outlook Calendar  OUTLOOK CALENDAR
Google Calendar  GOOGLE CALENDAR
ICal Calendar  ICAL CALENDAR
Yahoo! Calendar  YAHOO! CALENDAR

Hilton London Kensington

179-199 Holland Park Avenue
London W11 4UL
United Kingdom

Hilton London Kensington

At the heart of the Holland Park district, our hotel is 10 minutes from Westfield London shopping center. We're blocks from Shepherd's Bush Underground station, linking to central London, and Kensington Palace and Gardens are two miles from us. Enjoy 24-hour access to our fitness center.

 
Join us in WestEleven for hearty buffet breakfast, a great way to start the day! Our Avenue Bar and Lounge serves light bites throughout the day as well as a delicious, seasonal dining menu.”
HOTEL BOOKING FORM

Title

SubTitle
speaker image

Content


Title


Description

Download

Title


Description

Download

Title


Description


Download


WHAT IS CPD?

CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

CPD AND PROFESSIONAL INSTITUTES

There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

As a formal provider of CPD certified activities, SAE Media Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

GLOBAL CPD

Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

CPD Certificates

We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@saemediagroup.com

Event Title

Headline

Text
Read More

I would like to speak at an event

I would like to attend an event

Group Booking

Please complete the below form and a member of SAE Media Group’s booking team will be in contact within 24 hours

I would like to sponsor/exhibit at an event

SIGN UP OR LOGIN

Sign up
Forgotten Password?

Contact SAE Media Group

UK Office
Opening Hours: 9.00 - 17.30 (local time)
SAE Media Group , Ground Floor, India House, 45 Curlew Street, London, SE1 2ND, United Kingdom
Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
Website: http://www.smgconferences.com Email: events@saemediagroup.com
Registered in England - SMi Group Ltd trading as SAE Media Group




Forgotten Password

Please enter the email address you registered with. We will email you a new password.

Thank you for visiting our event

If you would like to receive further information about our events, please fill out the information below.

By ticking above you are consenting to receive information by email from SAE Media Group.
Full details of our privacy policy can be found here https://www.smgconferences.com/privacy-legals/privacy-policy/.
Should you wish to update your contact preferences at any time you can contact us at data.privacy@smgconferences.com.
Should you wish to be removed from any future mailing lists please click on the following link http://www.smgconferences.com/opt-out

Fill in your details to download the brochure

By submitting this form you agree to our privacy policy and consent to receiving communications, you may opt out at any time.

Join the loitering munitions community

Keep up to date with industry news, insights, and community updates FREE and direct to your inbox every month!
You can unsubscribe at any time. For full details see our Privacy Policy